With a phase 3 win for a combination of its TROP2-directed antibody-drug conjugate (ADC) sacituzumab tirumotecan (sac-TMT) ...

Dr. Charles M. Rudin highlighted new small cell lung cancer therapies, including T cell engagers, antibody-drug conjugates, ...

Kelun Biotech's sac-TMT plus Merck's Keytruda shows significant progress in late-stage lung cancer trial. Read more here.

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company", 6990.HK) announced today that the Independent Data ...

Although the Georgia congresswoman says she is “not running for president,” she’s got one of the best chances.

This growth is primarily driven by the rising global cancer incidence, increasing preference for non-invasive diagnostic ...

Bayer AG BAYRY announced that pipeline candidate asundexian met primary efficacy and safety endpoints in late-stage ...

Robert F. Kennedy Jr. somehow knew, even as a little boy, that fate can lead a person to terrible places. “I always had the ...

A speech delivered by Secretary of State for Science, Innovation, and Technology, Liz Kendall, at Innovation for Growth Summit on Monday 24 November ...

NASA satellites logged forty thousand to ninety thousand fires annually from 2021 to 2024, contributing up to forty percent ...

A Tulsa woman says lung cancer screenings saved her life. She told 2 News’ Naomi Keitt she’s advocating for others to get ...

Cancer screenings exist to try to detect the disease in its earlier stages, and ultimately to save lives. But screenings for ...